Episode #183 High Truths on Drugs and Addiction and Dr. Douglas Roehler on CDC Cannabis Unit

Episode 182 June 24, 2024 01:07:52
Episode #183 High Truths on Drugs and Addiction and Dr. Douglas Roehler on CDC Cannabis Unit
High Truths on Drugs and Addiction
Episode #183 High Truths on Drugs and Addiction and Dr. Douglas Roehler on CDC Cannabis Unit

Jun 24 2024 | 01:07:52

/

Show Notes

CDC has several different units working on different diseases and injury prevention, even one dedicated to cannabis.

To learn more about the CDC’s Cannabis Strategy Unit, I reached out to

Douglas Roehler, PhD, MPH

Health Scientist, Division of Overdose Prevention (DOP)

Douglas Roehler, PhD, MPH, serves as a Health Scientist for the Cannabis Strategy Unit in the Division of Overdose Prevention at CDC’s National Center for Injury Prevention and Control. His work has focused on coordinating and implementing CDC’s cannabis strategic plan, expanding cannabis surveillance and research, and building surveillance and prevention capacity for drug-related overdoses.

Prior to joining the Cannabis Strategy Unit, Dr. Roehler served as a Health Scientist on the Overdose Morbidity Team in the Epidemiology and Surveillance Branch in the Division of Overdose Prevention. In this role, he provided technical assistance to funded states to build and enhance their nonfatal overdose surveillance systems.

Previously, Dr. Roehler focused on building and improving road safety surveillance systems in low- and middle-income countries, preventing youth violence, and investigating sudden unexpected infant deaths. He earned his PhD and MPH in Health Behavior and Health Education at the University of Michigan School of Public Health. Following his doctoral work, he completed a postdoctoral fellowship at Rush University Medical Center in the Department of Pediatrics. He has published extensively on cannabis, drug overdoses, traffic safety, youth violence, and child injury prevention in peer-reviewed journals, MMWRs, book chapters, and governmental reports, including serving as the lead author of the 2019 Annual Surveillance Report of Drug-related Risks and Outcomes.

Other Episodes

Episode 100

November 21, 2022 00:45:29
Episode Cover

Episode #100 High Truths on Drugs and Addition with Sara Whaley on Opioid Settlement Best Practices

Sara Whaley worked on a model to make sure opioid settlement dollars are distributed fairly and effectively. The  historic pattern with tobacco has been: ...

Listen

Episode 52

December 20, 2021 00:51:45
Episode Cover

Episode #52 High Truths with Dr. Marta Sokolowska and Stimulant Use Disorder

The Western States are experiencing a greater problem with methamphetamines than with opioids. What are some treatment options for stimulant use disorder? Listen to...

Listen

Episode 228

May 05, 2025 01:06:43
Episode Cover

228. Carlton Hall | Transformational Leadership in Drug Prevention

Carlton Hall Consulting LLC (CHC) – Driving Global Change Through Community Solutions and Prevention Mastery Carlton Hall Consulting LLC (CHC) is a dynamic, full-service...

Listen